How does the razor-and-blade model affect purchasing decisions in the apheresis device segment?

Facilities face high switching costs once a platform is installed, since proprietary disposable kits must match the device manufacturer. Procurement teams should negotiate multi-year kit pricing before committing to a device vendor [7]. Read More

What accreditation standards apply to therapeutic apheresis programs in the United States?

The AABB and FACT (Foundation for Accreditation of Cellular Therapy) both offer voluntary accreditation programs covering personnel, quality systems, and procedure protocols. Many payers require AABB accreditation for reimbursement eligibility [3]. Read More

How are pathogen reduction technologies changing the apheresis value chain?

Systems like Cerus INTERCEPT treat apheresis-collected platelets and plasma to inactivate pathogens, reducing reliance on traditional screening. This adds a post-collection processing step and a new revenue layer for blood centers [23]. Read More

What role does apheresis play in pediatric transfusion medicine?

Pediatric patients require precisely dosed, single-donor components to minimize antigen exposure. Apheresis enables tailored component collection that whole-blood processing cannot match, making it standard in pediatric oncology centers [13]. Read More

How do leasing versus outright purchase models compare for emerging-market blood centers?

Leasing reduces upfront capital requirements and often bundles maintenance and training. Outright purchase offers lower total cost of ownership over a 10-year horizon but requires larger initial budgets [16]. Read More

What cybersecurity risks are emerging as apheresis devices become network-connected?

Connected platforms transmit donor and patient data, creating potential attack surfaces. The FDA's 2024 cybersecurity guidance now requires manufacturers to provide software bills of materials and patch management plans for networked medical devices [2]. Read More

How do mobile apheresis collection programs compare in cost-efficiency to fixed-site centers?

Mobile units carry higher per-procedure operating costs due to vehicle maintenance and logistical overhead, but they access donor populations that fixed sites cannot reach. Net collection volume gains typically offset the 15–20% cost premium [14]. Read More

Apheresis Market (2026 - 2035)

Apheresis Market Research Report By Product Type (Therapeutic Apheresis, Donor Apheresis, Plasma Apheresis, Cell Apheresis), By Application (Renal Disorders, Neurological Disorders, Cancer Treatment, Autoimmune Disorders), By End User (Hospitals, Blood Donation Centers, Research Laboratories), By Procedure Type (Manual Apheresis, Automated Apheresis) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2026-2035

CAGR

8.5%

2025 Market Size

USD 4.18 Billion

2035 Market Size

USD 9.45 Billion

Medical Device ● Updated August 24, 2026 Report ID: MRFR/MED/0979-HCR | Pages: 80 | Author: Nidhi Mandole, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Rising Autoimmune & Neurological Disease Prevalence | |
  2. 3.1.2 Expansion of Therapeutic Apheresis Indications | |
  3. 3.1.3 Blood Safety Regulation Tightening in Emerging Economies | |
  4. 3.1.4 Automation and AI Integration in Apheresis Devices | |
  5. 3.1.5 Growing Oncology Treatment Volumes | |
  6. 3.1.6 Donor Recruitment and Retention Programs | |
  7. 3.1.7 Emerging Market Healthcare Infrastructure Investment |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Capital Cost of Apheresis Equipment | |
  2. 3.2.2 Donor Adverse Reactions and Recruitment Challenges | |
  3. 3.2.3 Reimbursement Limitations for Therapeutic Procedures | |
  4. 3.2.4 Trained Operator Shortage | |
  5. 3.2.5 Supply Chain Vulnerabilities for Disposable Kits |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Point-of-Care and Portable Apheresis Systems | |
  2. 3.3.2 Expansion of Apheresis in Cell and Gene Therapy Manufacturing | |
  3. 3.3.3 Emerging Market Infrastructure Build-Out | |
  4. 3.3.4 Data-Driven Donor Management and Yield Optimization | |
  5. 3.3.5 Photopheresis for Transplant Medicine and Dermatology |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Apheresis Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product Type | |
  1. 5.1.1 Disposables & Kits | |
  2. 5.1.2 Apheresis Devices | |
  3. 5.1.3 Software & Automation |
2. 5.2 By Procedure Type | |
  1. 5.2.1 Plasmapheresis | |
  2. 5.2.2 Plateletpheresis | |
  3. 5.2.3 Leukapheresis | |
  4. 5.2.4 Erythrocytapheresis | |
  5. 5.2.5 Photopheresis |
3. 5.3 By End User | |
  1. 5.3.1 Hospitals & Clinics | |
  2. 5.3.2 Blood Collection Centers | |
  3. 5.3.3 Research Laboratories
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 France | |
  3. 6.2.3 United Kingdom | |
  4. 6.2.4 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Rest of Middle East & Africa
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Fresenius Kabi | |
  2. 7.3.2 Haemonetics Corporation | |
  3. 7.3.3 Terumo BCT | |
  4. 7.3.4 Asahi Kasei Medical | |
  5. 7.3.5 B. Braun Melsungen | |
  6. 7.3.6 Cerus Corporation | |
  7. 7.3.7 Kaneka Corporation | |
  8. 7.3.8 Miltenyi Biotec | |
  9. 7.3.9 Nikkiso Co., Ltd. | |
  10. 7.3.10 Mallinckrodt (Therakos)
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Enabled Procedure Optimization |
2. 8.2 Cell and Gene Therapy Manufacturing Integration |
3. 8.3 Sustainability and Green Blood Banking |
4. 8.4 Decentralized and Mobile Collection Models
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Apheresis Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Apheresis Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Apheresis Market – Driver Impact Analysis, 2026–2035 |
TABLE 4 Global Apheresis Market – Restraint Impact Analysis, 2026–2035 |
TABLE 5 Global Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 6 Global Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 7 Global Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Apheresis Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Apheresis Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Apheresis Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Apheresis Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Apheresis Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Apheresis Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 North America Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 15 North America Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 16 North America Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 17 Europe Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 18 Europe Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 19 Europe Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 20 Asia-Pacific Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 21 Asia-Pacific Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 22 Asia-Pacific Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 23 South America Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 24 South America Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 25 South America Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 26 Middle East & Africa Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 27 Middle East & Africa Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 28 Middle East & Africa Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 29 United States Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 30 United States Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 31 United States Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 32 China Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 33 China Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 34 China Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 35 Germany Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 36 Germany Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 37 Germany Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 38 India Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 39 India Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 40 India Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 41 Japan Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 42 Japan Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 43 Japan Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 44 Brazil Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 45 Brazil Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 46 Brazil Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 47 Saudi Arabia Apheresis Market Size, by Product Type, 2021–2035 (USD Billion) |
TABLE 48 Saudi Arabia Apheresis Market Size, by Procedure Type, 2021–2035 (USD Billion) |
TABLE 49 Saudi Arabia Apheresis Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 50 Competitive Benchmarking Matrix – Global Apheresis Market, 2025 |
TABLE 51 Company Profiles – Key Players, Global Apheresis Market |
TABLE 52 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 53 Report Scope & Methodology Summary
13 LIST OF FIGURES |
FIGURE 1 Global Apheresis Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Apheresis Industry Value Chain Analysis |
FIGURE 3 Porter's Five Forces Analysis — Global Apheresis Market |
FIGURE 4 Global Apheresis Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 5 Global Apheresis Market Share, by Product Type, 2025 (%) |
FIGURE 6 Global Apheresis Market Share, by Procedure Type, 2025 (%) |
FIGURE 7 Global Apheresis Market Share, by End User, 2025 (%) |
FIGURE 8 Global Apheresis Market Share, by Region, 2025 (%) |
FIGURE 9 North America Apheresis Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 10 Europe Apheresis Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 11 Asia-Pacific Apheresis Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 12 South America Apheresis Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 13 Middle East & Africa Apheresis Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 14 Competitive Landscape — Global Apheresis Market, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product Type	Disposables & Kits; Apheresis Devices; Software & Automation	Disposables & Kits	Apheresis Devices
By Procedure Type	Plasmapheresis; Plateletpheresis; Leukapheresis; Erythrocytapheresis; Photopheresis	Plasmapheresis	Photopheresis
By End User	Hospitals & Clinics; Blood Collection Centers; Research Laboratories	Hospitals & Clinics	Blood Collection Centers

Market Segmentation Overview

By Product Type

Sub-Segment	Key Trend
Disposables & Kits	Infection control mandates and closed-system protocols sustain recurring procurement demand.
Apheresis Devices	Next-generation automated platforms with AI integration drive premium pricing and fleet replacement
Software & Automation	Cloud-based donor management and yield optimization solutions create SaaS revenue streams.

Disposables and kits remain the revenue foundation of the apheresis industry, generating predictable demand through mandatory single-use protocols. The device segment is growing fastest in percentage terms as facilities across mature and emerging markets replace aging platforms with advanced automated systems offering improved collection efficiency and donor comfort.

By Procedure Type

Sub-Segment	Key Trend
Plasmapheresis	Global immunoglobulin demand continues to drive source plasma collection volumes.
Plateletpheresis	Single-donor platelet concentrates are preferred in oncology and surgical protocols.
Leukapheresis	Cell and gene therapy manufacturing creates a high-value demand channel.
Erythrocytapheresis	Sickle cell disease management programs expand in U.S. and European centers.
Photopheresis	GVHD treatment and transplant rejection indications broaden clinical adoption

Plasmapheresis dominates procedure volumes globally due to the surging demand for plasma-derived medicinal products. Photopheresis and leukapheresis represent the fastest-growing procedure categories, propelled by advances in transplant medicine and the explosive growth of the cell and gene therapy manufacturing pipeline.

By End User

Sub-Segment	Key Trend
Hospitals & Clinics	Therapeutic apheresis procedures for autoimmune, neurological, and hematological conditions
Blood Collection Centers	Source plasma and platelet collection for pharmaceutical and transfusion use
Research Laboratories	Leukapheresis material preparation for clinical trials and cell therapy R&D

Hospitals and clinics account for the largest share of end-user demand, performing the majority of therapeutic apheresis procedures. Blood collection centers represent the fastest-growing end-user segment as pharmaceutical companies expand contracted source plasma collection capacity to address persistent immunoglobulin supply shortages.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”